Medindia

X

FDA Gives Approval to Lupin to Market Generic Cipro in US

by Kathy Jones on  March 7, 2014 at 8:08 PM Drug News   - G J E 4
The US Food and Drug Administration has given approval for Mumbai-based pharmaceutical company Lupin to market the generic versions of Bayer's Cipro and Aqua Pharmaceuticals' Monodox capsules in the American market.
 FDA Gives Approval to Lupin to Market Generic Cipro in US
FDA Gives Approval to Lupin to Market Generic Cipro in US
Advertisement

Confirming the approval, the company said that it has received permission to market Cipro oral suspension in 250 mg/ml and 500 mg/ml strengths while its Doxycycline Capsules, which are equivalent to Monodox capsules, will be marketed in strengths of 50mg, 75mg and 100mg.

Advertisement
Cipro is used in treating infections caused by susceptible isolates of the designated microorganisms in various conditions and patient populations while Monodox is used as an adjunctive therapy for severe acne

"Lupin is the first applicant to file an abbreviated new drug application (ANDA) for Cipro oral suspension 250 mg/ml & 500 mg/ml and as such is entitled to 180 days of marketing exclusivity. Lupin Pharmaceuticals Inc. (LPI), the company's US subsidiary would commence marketing the products shortly", the company said in a statement.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All